Related Experiment Video
Updated: Jan 30, 2026

Author Spotlight: Manipulating Signaling in Zebrafish Embryos to Decode Cell Fate Decisions
Published on: October 27, 2023
Cannabidiol modulates phosphorylated rpS6 signalling in a zebrafish model of Tuberous Sclerosis Complex
Ines Serra1, Chloë Scheldeman2, Michael Bazelot3
1School of Psychology and Clinical Language Sciences, University of Reading, Reading, UK; School of Pharmacy, University of Reading, Reading, UK.
Abstract:
Tuberous sclerosis complex (TSC) is a rare disease caused by mutations in the TSC1 or TSC2 genes and is characterized by widespread tumour growth, intractable epilepsy, cognitive deficits and autistic behaviour. CBD has been reported to decrease seizures and inhibit tumour cell progression, therefore we sought to determine the influence of CBD on TSC pathology in zebrafish carrying a nonsense mutation in the tsc2 gene. CBD treatment from 6 to 7 days post-fertilization (dpf) induced significant anxiolytic actions without causing sedation. Furthermore, CBD treatment from 3 dpf had no impact on tsc2-/- larvae motility nor their survival. CBD treatment did, however, reduce the number of phosphorylated rpS6 positive cells, and their cross-sectional cell size. This suggests a CBD mediated suppression of mechanistic target of rapamycin (mTOR) activity in the tsc2-/- larval brain. Taken together, these data suggest that CBD selectively modulates levels of phosphorylated rpS6 in the brain and additionally provides an anxiolytic effect. This is pertinent given the alterations in mTOR signalling in experimental models of TSC. Additional work is necessary to identify upstream signal modulation and to further justify the use of CBD as a possible therapeutic strategy to manage TSC.
Insights
Cannabidiol (CBD) demonstrated anxiolytic effects in zebrafish with tuberous sclerosis complex (TSC) mutations. CBD also reduced key indicators of TSC pathology, suggesting potential therapeutic benefits for this rare genetic disorder.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Tuberous sclerosis complex (TSC) is a rare genetic disorder caused by mutations in TSC1 or TSC2 genes.
- TSC is characterized by tumor growth, epilepsy, cognitive deficits, and autistic behaviors.
- Cannabidiol (CBD) shows promise in reducing seizures and inhibiting tumor progression.
Purpose of the Study:
- To investigate the effects of CBD on TSC pathology in a zebrafish model with a tsc2 gene mutation.
- To assess CBD's impact on anxiety-like behaviors, motility, and survival in tsc2-/- zebrafish larvae.
- To determine if CBD modulates mTOR signaling pathway activity in the affected zebrafish brain.
Main Methods:
- Utilized a zebrafish model with a nonsense mutation in the tsc2 gene.
- Administered CBD treatment during specific developmental stages (3-7 days post-fertilization).
- Assessed behavioral changes (anxiety, motility), survival rates, and quantified phosphorylated rpS6 positive cells and cell size in the brain.
Main Results:
- CBD treatment induced significant anxiolytic effects without causing sedation in tsc2-/- zebrafish.
- CBD did not negatively impact larval motility or survival rates.
- CBD treatment reduced the number and size of phosphorylated rpS6 positive cells in the brain, indicating suppressed mTOR activity.
Conclusions:
- CBD exhibits anxiolytic properties and selectively modulates phosphorylated rpS6 levels in the brain of tsc2-/- zebrafish.
- These findings suggest CBD may suppress mTOR signaling, a pathway implicated in TSC.
- Further research is warranted to explore upstream signaling and validate CBD as a potential therapeutic strategy for TSC management.
Related Concept Videos
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Endocrine Signaling
Intracellular Signaling Cascades
Small-signal Diode Model
Yeast Signaling

